Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Fremont. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Fremont at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
This is a multinational, multicenter, randomized, double-blind, placebo-controlled, parallel, Phase 3 study for treatment of participants aged 12 years and older diagnosed with moderate-to-severe atopic dermatitis (AD). The main objective of this study is to evaluate if those participants who received amlitelimab dose 1 in the parent studies (EFC17559 \[COAST-1\], EFC17560 \[COAST 2\], EFC17561 \[SHORE\]) and were responders can maintain their response either remaining at dose 1 or switching to
Sponsor: Sanofi
Check if you qualify for this atopic dermatitis clinical trial in Fremont, CA
If you're searching for atopic dermatitis treatment options in Fremont, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Fremont research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.